Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global End-Stage Kidney Disease Market Size Analysis from 2022 to 2027

1.5.1 Global End-Stage Kidney Disease Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global End-Stage Kidney Disease Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global End-Stage Kidney Disease Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: End-Stage Kidney Disease Industry Impact

Chapter 2 Global End-Stage Kidney Disease Competition by Types, Applications, and Top Regions and Countries

2.1 Global End-Stage Kidney Disease (Volume and Value) by Type

2.1.1 Global End-Stage Kidney Disease Consumption and Market Share by Type (2016-2021)

2.1.2 Global End-Stage Kidney Disease Revenue and Market Share by Type (2016-2021)

2.2 Global End-Stage Kidney Disease (Volume and Value) by Application

2.2.1 Global End-Stage Kidney Disease Consumption and Market Share by Application (2016-2021)

2.2.2 Global End-Stage Kidney Disease Revenue and Market Share by Application (2016-2021)

2.3 Global End-Stage Kidney Disease (Volume and Value) by Regions

2.3.1 Global End-Stage Kidney Disease Consumption and Market Share by Regions (2016-2021)

2.3.2 Global End-Stage Kidney Disease Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global End-Stage Kidney Disease Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global End-Stage Kidney Disease Consumption by Regions (2016-2021)

4.2 North America End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.4 Europe End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.8 Africa End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

4.10 South America End-Stage Kidney Disease Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America End-Stage Kidney Disease Market Analysis

5.1 North America End-Stage Kidney Disease Consumption and Value Analysis

5.1.1 North America End-Stage Kidney Disease Market Under COVID-19

5.2 North America End-Stage Kidney Disease Consumption Volume by Types

5.3 North America End-Stage Kidney Disease Consumption Structure by Application

5.4 North America End-Stage Kidney Disease Consumption by Top Countries

5.4.1 United States End-Stage Kidney Disease Consumption Volume from 2016 to 2021

5.4.2 Canada End-Stage Kidney Disease Consumption Volume from 2016 to 2021

5.4.3 Mexico End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 6 East Asia End-Stage Kidney Disease Market Analysis

6.1 East Asia End-Stage Kidney Disease Consumption and Value Analysis

6.1.1 East Asia End-Stage Kidney Disease Market Under COVID-19

6.2 East Asia End-Stage Kidney Disease Consumption Volume by Types

6.3 East Asia End-Stage Kidney Disease Consumption Structure by Application

6.4 East Asia End-Stage Kidney Disease Consumption by Top Countries

6.4.1 China End-Stage Kidney Disease Consumption Volume from 2016 to 2021

6.4.2 Japan End-Stage Kidney Disease Consumption Volume from 2016 to 2021

6.4.3 South Korea End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 7 Europe End-Stage Kidney Disease Market Analysis

7.1 Europe End-Stage Kidney Disease Consumption and Value Analysis

7.1.1 Europe End-Stage Kidney Disease Market Under COVID-19

7.2 Europe End-Stage Kidney Disease Consumption Volume by Types

7.3 Europe End-Stage Kidney Disease Consumption Structure by Application

7.4 Europe End-Stage Kidney Disease Consumption by Top Countries

7.4.1 Germany End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.2 UK End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.3 France End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.4 Italy End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.5 Russia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.6 Spain End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.7 Netherlands End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.8 Switzerland End-Stage Kidney Disease Consumption Volume from 2016 to 2021

7.4.9 Poland End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 8 South Asia End-Stage Kidney Disease Market Analysis

8.1 South Asia End-Stage Kidney Disease Consumption and Value Analysis

8.1.1 South Asia End-Stage Kidney Disease Market Under COVID-19

8.2 South Asia End-Stage Kidney Disease Consumption Volume by Types

8.3 South Asia End-Stage Kidney Disease Consumption Structure by Application

8.4 South Asia End-Stage Kidney Disease Consumption by Top Countries

8.4.1 India End-Stage Kidney Disease Consumption Volume from 2016 to 2021

8.4.2 Pakistan End-Stage Kidney Disease Consumption Volume from 2016 to 2021

8.4.3 Bangladesh End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia End-Stage Kidney Disease Market Analysis

9.1 Southeast Asia End-Stage Kidney Disease Consumption and Value Analysis

9.1.1 Southeast Asia End-Stage Kidney Disease Market Under COVID-19

9.2 Southeast Asia End-Stage Kidney Disease Consumption Volume by Types

9.3 Southeast Asia End-Stage Kidney Disease Consumption Structure by Application

9.4 Southeast Asia End-Stage Kidney Disease Consumption by Top Countries

9.4.1 Indonesia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.2 Thailand End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.3 Singapore End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.4 Malaysia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.5 Philippines End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.6 Vietnam End-Stage Kidney Disease Consumption Volume from 2016 to 2021

9.4.7 Myanmar End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 10 Middle East End-Stage Kidney Disease Market Analysis

10.1 Middle East End-Stage Kidney Disease Consumption and Value Analysis

10.1.1 Middle East End-Stage Kidney Disease Market Under COVID-19

10.2 Middle East End-Stage Kidney Disease Consumption Volume by Types

10.3 Middle East End-Stage Kidney Disease Consumption Structure by Application

10.4 Middle East End-Stage Kidney Disease Consumption by Top Countries

10.4.1 Turkey End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.3 Iran End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.5 Israel End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.6 Iraq End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.7 Qatar End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.8 Kuwait End-Stage Kidney Disease Consumption Volume from 2016 to 2021

10.4.9 Oman End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 11 Africa End-Stage Kidney Disease Market Analysis

11.1 Africa End-Stage Kidney Disease Consumption and Value Analysis

11.1.1 Africa End-Stage Kidney Disease Market Under COVID-19

11.2 Africa End-Stage Kidney Disease Consumption Volume by Types

11.3 Africa End-Stage Kidney Disease Consumption Structure by Application

11.4 Africa End-Stage Kidney Disease Consumption by Top Countries

11.4.1 Nigeria End-Stage Kidney Disease Consumption Volume from 2016 to 2021

11.4.2 South Africa End-Stage Kidney Disease Consumption Volume from 2016 to 2021

11.4.3 Egypt End-Stage Kidney Disease Consumption Volume from 2016 to 2021

11.4.4 Algeria End-Stage Kidney Disease Consumption Volume from 2016 to 2021

11.4.5 Morocco End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 12 Oceania End-Stage Kidney Disease Market Analysis

12.1 Oceania End-Stage Kidney Disease Consumption and Value Analysis

12.2 Oceania End-Stage Kidney Disease Consumption Volume by Types

12.3 Oceania End-Stage Kidney Disease Consumption Structure by Application

12.4 Oceania End-Stage Kidney Disease Consumption by Top Countries

12.4.1 Australia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

12.4.2 New Zealand End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 13 South America End-Stage Kidney Disease Market Analysis

13.1 South America End-Stage Kidney Disease Consumption and Value Analysis

13.1.1 South America End-Stage Kidney Disease Market Under COVID-19

13.2 South America End-Stage Kidney Disease Consumption Volume by Types

13.3 South America End-Stage Kidney Disease Consumption Structure by Application

13.4 South America End-Stage Kidney Disease Consumption Volume by Major Countries

13.4.1 Brazil End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.2 Argentina End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.3 Columbia End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.4 Chile End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.5 Venezuela End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.6 Peru End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico End-Stage Kidney Disease Consumption Volume from 2016 to 2021

13.4.8 Ecuador End-Stage Kidney Disease Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in End-Stage Kidney Disease Business

14.1 Nipro Corporation

14.1.1 Nipro Corporation Company Profile

14.1.2 Nipro Corporation End-Stage Kidney Disease Product Specification

14.1.3 Nipro Corporation End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Cantel Medical

14.2.1 Cantel Medical Company Profile

14.2.2 Cantel Medical End-Stage Kidney Disease Product Specification

14.2.3 Cantel Medical End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Medtronic Plc

14.3.1 Medtronic Plc Company Profile

14.3.2 Medtronic Plc End-Stage Kidney Disease Product Specification

14.3.3 Medtronic Plc End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Fresenius Medical Care

14.4.1 Fresenius Medical Care Company Profile

14.4.2 Fresenius Medical Care End-Stage Kidney Disease Product Specification

14.4.3 Fresenius Medical Care End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Asahi Kasei Medical Co., Ltd.

14.5.1 Asahi Kasei Medical Co., Ltd. Company Profile

14.5.2 Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Product Specification

14.5.3 Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Baxter International, Inc.

14.6.1 Baxter International, Inc. Company Profile

14.6.2 Baxter International, Inc. End-Stage Kidney Disease Product Specification

14.6.3 Baxter International, Inc. End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 JMS Co. Ltd.

14.7.1 JMS Co. Ltd. Company Profile

14.7.2 JMS Co. Ltd. End-Stage Kidney Disease Product Specification

14.7.3 JMS Co. Ltd. End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 BD

14.8.1 BD Company Profile

14.8.2 BD End-Stage Kidney Disease Product Specification

14.8.3 BD End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 B. Braun Melsungen AG

14.9.1 B. Braun Melsungen AG Company Profile

14.9.2 B. Braun Melsungen AG End-Stage Kidney Disease Product Specification

14.9.3 B. Braun Melsungen AG End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Nikkiso Co., Ltd

14.10.1 Nikkiso Co., Ltd Company Profile

14.10.2 Nikkiso Co., Ltd End-Stage Kidney Disease Product Specification

14.10.3 Nikkiso Co., Ltd End-Stage Kidney Disease Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global End-Stage Kidney Disease Market Forecast (2022-2027)

15.1 Global End-Stage Kidney Disease Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global End-Stage Kidney Disease Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global End-Stage Kidney Disease Value and Growth Rate Forecast (2022-2027)

15.2 Global End-Stage Kidney Disease Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global End-Stage Kidney Disease Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global End-Stage Kidney Disease Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America End-Stage Kidney Disease Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global End-Stage Kidney Disease Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global End-Stage Kidney Disease Consumption Forecast by Type (2022-2027)

15.3.2 Global End-Stage Kidney Disease Revenue Forecast by Type (2022-2027)

15.3.3 Global End-Stage Kidney Disease Price Forecast by Type (2022-2027)

15.4 Global End-Stage Kidney Disease Consumption Volume Forecast by Application (2022-2027)

15.5 End-Stage Kidney Disease Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology